Myeloid Neoplasm — Trials

Myeloid Neoplasm — Trials · CancerIndex

Clinical trials

Registered studies

4,789 studies whose conditions map to this entity or one of its descendants. Status and phase are as posted on ClinicalTrials.gov. 50 studies per page.

clinicaltrialsPublishedShowing 1–50 of 89 studies matching the filters · status and phase as posted by the registrant; each row links to the study record.

NCT	Title	Status	Phase	Enrollment (n)	Sponsor	Countries	Last update	Source
NCT06597734	A Phase 2 Study Evaluating Olutasidenib in Combination With Hypomethylating Agents in Patients With IDH1-mutated Higher-risk Myelodysplastic Syndromes, Chronic Myelomonocytic Leukemia, or Advanced Myeloproliferative Neoplasm	withdrawn	Phase 2	0	M.D. Anderson Cancer CenterOTHER	0	Sep 11, 2026	clinicaltrials
NCT07387354	Pacritinib With Aza for Upfront Myelodysplastic Syndrome(MDS)	withdrawn	Phase 1 / Phase 2	0	Thomas Jefferson UniversityOTHER	0